🫁 BNP/NT-proBNP Lab Marker Interpretation Simulator

Ventricular Wall Stretch as the Trigger Signal

Increased wall tension is the mechanical trigger for peptide release.

• Wall tension: Trigger (Volume/pressure overload)
• Cardiomyocytes: Source cells (mainly ventricular)
• Stretch receptors: Sensing (mechanosensitive)
• Minutes: Onset (rapid transcription)

Mechanism of stretch sensing

Wall stretch activates gene transcription for natriuretic peptides.

Release of BNP and NT-proBNP Into Circulation

ProBNP is cleaved into active BNP and inactive NT-proBNP fragments.

• proBNP-108: Precursor (cleaved by corin)
• BNP-32: Active form (short half-life ~20min)
• NT-proBNP: Inactive form (half-life ~120min)
• 1:1 molar: Ratio (equimolar cleavage)

Cleavage and clearance

Longer half-life makes NT-proBNP a more stable lab marker.

Interpreting Normal Ranges by Patient Age

Normal thresholds rise with age due to natural cardiac changes.

• <450 pg/mL: Age <50 (normal cutoff)
• <900 pg/mL: Age 50-75 (normal cutoff)
• <1800 pg/mL: Age >75 (normal cutoff)
• Fibrosis/renal: Reason (age-related decline)

Why age matters

Renal clearance and stiffness both raise baseline levels with age.

Diagnostic Threshold for Heart Failure

Levels above the age-adjusted threshold raise heart failure likelihood.

• <300 pg/mL: Rule-out (NT-proBNP, acute setting)
• Age-based: Rule-in (450/900/1800 pg/mL)
• High: Sensitivity (good for ruling out)
• Renal, obesity: Confounders (shift interpretation)

Threshold caveats

Obesity lowers levels; renal impairment raises them independent of HF.

Trend Interpretation Across Serial Measurements

Change over time often matters more than a single value.

• Worsening: Rising trend (decompensation risk)
• Improving: Falling trend (therapy response)
• >30-50%: Significant Δ (biologic variability)
• HF titration: Use case (guides therapy)

Trend over single value

Serial trends help guide diuretic and therapy adjustments.

Placeholder: track the trend, not just one number.